Ingles Markets Q1 2026 Earnings EPS of 128 Supports Stock Gain Amid Limited Disclosure ANNX Q1 2026 Earnings Narrower Loss Beats Estimates Stock Declines on PreRevenue Status FPH Q1 2026 Earnings Narrowing Loss Amid Challenging Market Conditions DRMA Q1 2026 Earnings NarrowerthanExpected Loss Marks Progress for ClinicalStage Biotech SCWO Q1 2026 Earnings PreRevenue Stage Continues as Net Loss Widens